Details of Drug Bulletin:
“Drug Bulletin” is quarterly journal (ISSN 0970-2229) published by department of Pharmacology, PGIMER, Chandigarh. The first issue was published in 1975. The journal is published in January, April, July and October every year. This journal contains reviews on important topics by reputed authors. The journal went online from 2013 issues onwards.
The bulletin is registered under “International society of Drug Bulletins” and World Health Organization (WHO) has published a case study on “Drug Bulletin”, PGIMER in their article on “Starting or Strengthening a Drug Bulletin - A Practical Manual”.
Target audience of the journal: Doctors working in periphery, medical scientists, pharmacologists, basic medical scientists.
- ICMJE guideline to be followed.
- Review can be mailed to firstname.lastname@example.org
- Articles will be subjected to a double blind peer review system.
- Only high quality articles successfully defending peer review system will be accepted for publication.
- Articles above similarity index of >10% will not be published.
- Articles will be published both online and in print.
Current Drugs bulletin committee
Prof. A. Chakrabarti
Prof. Samir Malhotra
Prof. Bikash Medhi
Dr. Debashis Hota
Dr. Nusrat Shafiq
Dr. Lekha Saha
Dr. Smita Pattanaik
Advisory committee chairman
Prof. Y. Chawla
Prof. Amod Gupta
Prof. V. Sakhuja
Prof. K. Joshi
Prof. S K Jindal
Prof. Bikash Medhi
Dr. Ajay Prakash
|Assiatant editor||Dr. Phulen Sarma|
Ms. Sukhmeet Kaur
|Journal Designer||Mr. Shammy Chandel|
Now we are completing the backlog of 2016 April-2019 issues.
Drug bulletin details.
Volume and issue
Sarma P, Radhika A, Chakrabarti A, Medhi B. Newer Antiepileptic Drugs. 2013 38(2): 1-45
Shyambalaji A, Sarma P, Medhi B, Chakrabarti A. Lifestyle drugs. 2013 38(2): 1-21
Krishnamurthy B, Medhi B. Gestational Diabetes Mellitus. 2013 38(3): 1-29
Bhagat R, Kumar H, Sarma P, Singh S, Chakrabarti A, Medhi B. Orphan Drug and Disease. 2013 38(4): 1-27
Singh S, Chandel S, Bhagat R, Medhi B. Quality of Medicine. Drug bulletin 2014:39 (1): 1-5
Radhika A, Sarma P, Medhi B. Personalized therapy: Current prospects and practical implications. Drug bulletin 2014: 39 (2): 1-9
Bhagat R, Kumar H, Sarma P, Mishra A, Medhi B. Drug eluting stents. Drug Bulletin 2014: 39 (3): 1-9
Reddy DH, Soni H, Chandel S, Medhi B. Post stroke dementia and treatment. Drug Bulletin 2014: 39 (4): 1-8
Soni S, Sarma P, Medhi B. Materivigilance: Indian perspective. Drug bulletin 2015: 40 (1): 1-15
| ||April 2015|
Rohila R, Kumar P, Naveen M, Medhi B. Novel ocular drug delivery methods. Drug Bulletin 2015. 40(2): 1-10
| ||July 2015||Krishnamurthy B, Medhi B. MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT. Drug Bulletin 2015; 40(3): 1]17. |
| ||October 2015|
Mothsara C, Patil A. Alternative therapy, Safety and efficacy: A Critical analysis with respect to Indian scenario. Drug Bulletin 2015; 40(4): 1-8
Sahoo S, Padhy SK, Avasthi A. An update on the newer antipsychotics: last decade. Drug Bulletin 2016; 41(1): 1-12
| ||April 2016||Mahendru D, Kumar S, Kaur S, Prakash A, Medhi B. Sports medicine team: the background players behind a successful athlete. Drug Bulletin 2016; 41(2): 1-14.|
| ||July 2016|| Vishwas G, Kakkar K A. Newer Antimicrobials and Real World. Drug Bulletin 2016; 41(3): 1-9|
|October 2016|| CVN H, Prakash A. Snake Bite. Drug Bulletin 2016; 41(4): 1-12.|
|2017||January 2017||Thota P, Thota A, Sarma P, Prakash A, Medhi B. The startle reality of medication errors in India: role of pharmacovigilance. Drug Bulletin 2017; 42(1): 1-4.|
| ||April 2017||Manav J, Ajay P, Bikash M. Research and development in the management of HIV: Imposition of Newer drug therapy: Drug Bulletin 2017; 42(2): 1-19 |
| ||July 2017||Kondel R, Pandey AK, Gani Rather II, Medhi B. Hypertension and adherence. Drug Bulletin 2017; 42(3): 1-12.|
| ||October 2017||Mishra A, Singla R,Sarma P, Rajput R,Sharma AR, Medhi B. Pharmacotherapy of Autism. Drug Bulletin 2017; 42(4): 1-14.|
|2018||January 2018||Jain A, Prakash A, Medhi B. Orphan drugs. Drug Bulletin 2018; 43(1): 1-6.|
| ||April 2018||Mahajan E, Medhi B. Memory Enhancer? Drug Bulletin 2018; 43(2):1-8|
| ||July 2018||Boparai JK, Medhi B, Singh S. Asthma, a chronic inflammatory respiratory disease: An update. Drug bulletin 2018; 43 (3): 1-14. |
| ||October 2018||Dhir N, Prakash A, Medhi B. Current updates in the management of acute ischemic stroke. Drug Bulletin 2018; 43(4): 1-6.|
|2019||January 2019||Vel K, Ajay P, Bikash M. Stem Cell Research: Current Update On Efficacy and Safety. Drug Bulletin 2019; 44(1): 1-6.|
| ||April 2019||Devraj, Medhi B. Swine Flu. Drug Bulletin 2019; 44(2): 1-11.|
| ||July 2019|| Singh A, Singh RS, Sarma P, Kaur H, Mahendiratta S, Batra G, Sharma AJ, Medhi B. Current drug therapies under development in Celiac disease. Drug Bulletin 2019; 44(3): 1-7.|
| ||October 2019|| Mahajan S, Tandon V, Gupta B. Pharmacotherapy of postpartum depression. Drug Bulletin 2019; 44(4): 1-10.|
Table of Contents:
1. Bhattacharjee S, Medhi B. Management of Hepatitis C- Current Update. Drug Bulletin 2020; 45: 1-7.
2. Mahendru D, Vidya M. Mahalmani, Kumaravel J, Gitika Batra, Prakash A, Medhi B. Recent advances in treatment of myasthenia gravis. Drug Bulletin 2020; 45: 8-15.
3. Semwal A, Kaur S, Prakash A, Medhi B. Drug Therapy for recent viral epidemic & pandemic. Drug Bulletin 2020; 45: 16-22.